Clin2
NCT06749613Possibly a fitRecruiting

Digestive enzymes for IBS after diet response

Irritable Bowel Syndrome

Part of Digestive system clinical trials.

This trial tests whether a digestive enzyme supplement can help people with irritable bowel syndrome (IBS) whose symptoms returned after they previously improved on a special low-FODMAP Mediterranean diet.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
40 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You must have IBS (diarrhea type, mixed type, or unspecified type) as diagnosed by Rome IV criteria.
  • You must have taken part in a previous diet study (NCT03997708) and were assigned to the Mediterranean low-FODMAP diet group.
  • You either had a good response to that diet but symptoms returned (IBS severity score over 175) a year later, or you couldn't stick with the diet.
  • You are willing to take a digestive enzyme supplement and follow the study schedule.
  • You are not eligible if you were in the other group (NICE) of the previous study or if your IBS symptoms are currently mild (score under 175).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07467278Not yet recruiting
Low-FODMAP diet for irritable bowel syndrome

This trial tests whether a low-FODMAP diet (a diet that avoids certain carbohydrates that can cause bloating and gas) can improve gut health in people with Irritable Bowel Syndrome. If you have IBS, this diet might help reduce your symptoms and improve how well your intestines work.

NCT07039747Recruiting· Phase 2
Can a dietary supplement help people with irritable bowel syndrome?

This trial is testing if a dietary supplement can reduce symptoms of irritable bowel syndrome (IBS). You might qualify if you have been diagnosed with IBS, have moderate to severe symptoms, and are between 18 and 75 years old.

Rouen, France
NCT05120752Recruiting· Phase 3
Low FODMAP diet trial for IBS without lactose intolerance

This trial tests whether eating a low-FODMAP diet can reduce IBS symptoms in people who do not have lactose intolerance. It aims to improve moderate-to-severe IBS symptoms by changing what kinds of carbohydrates you eat.

Jette, Brussels Capital
NCT05972317Recruiting
Personalized diet vs low FODMAP diet for irritable bowel syndrome

This study compares two diet plans for people with irritable bowel syndrome (IBS): a personalized diet tailored to your specific triggers and the low FODMAP diet, which avoids certain carbohydrates that can cause gas and bloating. The goal is to see which approach works better for relieving symptoms.

Rehovot
NCT07716852Not yet recruiting
Testing a probiotic supplement for irritable bowel syndrome

This study tests a dietary supplement called Enzymax DuoBiotics to see if it helps ease irritable bowel syndrome (IBS) symptoms like belly pain and irregular bowel habits. If you have IBS and are looking for a non-drug option, this may be a good fit.

NCT07494968Recruiting
Finding ways to track diet compliance in IBS patients

This study looks for signs in your body—like breath and blood tests—that can show how well you are following a special diet for IBS. It aims to find better ways to track diet compliance, which could help make dietary treatments more effective.

Ann Arbor, Michigan

Hear when a new Irritable Bowel Syndrome trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.